| 06:11a | ABERA BIOSCIENCE : France's Avril in talks with Bigard group to sell two pork firms | RE |
| 05:57a | ViiV Gets FDA Priority Review for Cabotegravir Long-Acting for HIV Prevention | DJ |
| 05:35a | Regeneron Gets FDA Priority Review of Libtayo in Advanced Cervical Cancer | DJ |
| 05:15a | Pfizer, BioNTech to Request FDA Emergency-Use Authorization for Covid-19 Shot in Children in Coming Weeks | DJ |
| 04:57a | Lilly Cuts List Price of Insulin Lispro Injection | DJ |
| 04:30a | LOTUS PHARMACEUTICALS : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund | RE |
| 03:34a | NOVO NORDISK : JP Morgan reiterates its Buy rating | MD |
| 03:05a | AMP Alternative Medical Products Inc. Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany | CI |
| 02:57a | Sanofi to Halt MRNA Covid-19 Vaccine Development Despite Positive Trial Results -- Update | DJ |
| 02:13a | Sanofi to Halt MRNA Covid-19 Vaccine Development | DJ |
| 02:00a | Animalcare Group plc Declares Interim Dividend, Payable on 19 November 2021 | CI |
| 02:00a | Episurf Medical AB Investigates the Opportunities for Launching an Implant for the MTP Joint in the US Market | CI |
| 02:00a | AstraZeneca's Saphnelo Approves in Japan for Systemic Lupus Erythematosus | CI |
| 02:00a | Sourcebio International plc Reports Consolidated Earnings Results for the Six Months Ended 30 June 2021 | CI |
| 02:00a | Yourgene Health plc Provides Revenue Guidance for the First Half Year to September 30, 2021 | CI |
| 02:00a | Bonesupport Announces Supplementary US Denovo Application Submitted | CI |
| 02:00a | 4basebio PLC Commences Development of its Pilot Clean Room Project for the Purpose of Manufacturing GMP Standard DNA | CI |
| 02:00a | Oxford Biodynamics Plc Completes Its Move into Its New Purpose-Built Facility on the Oxford Business Park | CI |
| 02:00a | Sanofi Announces Positive Phase 1/2 Study Interim Results for Its First mRNA-Based Vaccine Candidate | CI |
| 02:00a | Sedana Medical Receives Approval in Germany | CI |
| 01:01a | Relief Reports that its U.S. Collaboration Partner has Announced Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMITM (RLF-100TM/aviptadil) | DJ |
| 01:00a | Kuros Biosciences to Showcase New Magnetos Products At Nass 2021 Annual Meeting | CI |
| 01:00a | Valneva and Pfizer Reports Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate | CI |
| 01:00a | Bone Therapeutics Signs Research Partnership with Implant Therapeutics to Access Induced Pluripotent Stem Cells | CI |
| 12:50a | AstraZeneca's Saphnelo Approved in Japan for SLE | DJ |
| 12:33a | Sanofi Reports Encouraging Early Results In Covid-19 mRNA Vaccine Candidate | DJ |
| 09/28 | Certain A Shares of Imeik Technology Development Co.,Ltd. are subject to a Lock-Up Agreement Ending on 28-SEP-2021. | CI |
| 09/28 | Certain A Shares of Touchstone International Medical Science Co., Ltd. are subject to a Lock-Up Agreement Ending on 28-SEP-2021. | CI |
| 09/28 | Brii Biosciences Limited Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy | CI |
| 09/27 | Shionogi & Co., Ltd. Announces Initiation of A Phase 2/3 Clinical Trial for A COVID-19 Therapeutic Agent in Japan | CI |
| 09/27 | Imricor Medical Systems, Inc. Enters into a Sales Distribution Agreement with MiRTLE Medical, LLC | CI |
| 09/27 | BioArctic AB's partner Eisai Initiates Rolling Submission for the US FDA Biologics License Application of Lecanemab for Early Alzheimer’s Disease Under the Accelerated Approval Pathway | CI |
| 09/27 | Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab For Early Alzheimer's Disease Under The Accelerated Approval Pathway | CI |
| 09/27 | AURORA CANNABIS : revenue falls short of expectations on lower pot demand | RE |
| 09/27 | LBT Innovations Limited Appoints Brian O'Dwyer to Its Board as a Non-Executive Director, Commencing 4 October 2021 | CI |
| 09/27 | Merck Reportedly in Advanced Talks to Buy Acceleron Pharma | CI |
| 09/27 | ACCELERON PHARMA : Merck in advanced talks to buy Acceleron Pharma - WSJ | RE |
| 09/27 | Teligent, Inc. Announces Executive Changes | CI |
| 09/27 | Centene Corporation Announces Resignation of Jeffrey A. Schwaneke as Executive Vice President of Healthcare Enterprises of Centene | CI |
| 09/27 | Gilead Announces Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization | CI |
| 09/27 | Hologic, Inc. Together with Certain of its Subsidiaries Enters into Refinancing Amendment No. 2 to its Amended and Restated Credit and Guaranty Agreement | CI |
| 09/27 | Globus Medical, Inc. Announces First ExcelsiusGPS® Cranial Surgery | CI |
| 09/27 | Pfizer Inc. Announces First Participants Dosed in Phase 1 Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Single Dose Quadrivalent mRNA Vaccine Against Influenza in Healthy Adults | CI |
| 09/27 | Assisted 4 Living, Inc. Appoints David Verinder to the Board of Directors of the Company | CI |
| 09/27 | Natus Medical Incorporated Receives Key New Government Contract | CI |
| 09/27 | Summers Value Partners Enters into Cooperation Agreement with Electromed | CI |
| 09/27 | Biodelivery Sciences International, Inc. Elects to Repay $20 Million Plus Accrued Interest, Representing A Portion of the First Tranche of Its Previously Disclosed Loan Agreement with BPCR Limited Partnership | CI |
| 09/27 | Becton, Dickinson and Company Enters into an Amended and Restated Credit Agreement | CI |
| 09/27 | Brookdale Senior Living Inc. to Offer $200 Million Convertible Senior Notes Due 2026 | CI |
| 09/27 | Vapotherm, Inc. Announces Executive Changes | CI |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
